Efficacy of Flexible Neuroendoscopy With Dry-Field Techniques for Chronic Subdural Hematoma Treatment
Chronic subdural hematoma (CSDH)—a slow-growing blood collection between the brain and its outer membrane—is one of the most common neurosurgical conditions, accounting for ~10% of all intracranial hematomas. It’s especially prevalent in older adults, where brain atrophy widens the space between the brain and skull, making small blood vessels (like bridge veins) more prone to tearing and bleeding. While surgery is the gold standard for treatment, traditional burr-hole drainage—drilling a small skull hole to drain the hematoma—often comes with tradeoffs: high recurrence rates (up to 15%) and complications like pneumocephalus (air in the skull) or subdural effusion.
A 2019 study from Beijing Shijitan Hospital, Capital Medical University tested a new approach: combining flexible neuroendoscopy (a thin, bendable camera) with dry-field techniques (DFT)—operating in an emptied, fluid-free hematoma cavity—to improve CSDH outcomes. The results suggest this method could be a game-changer for patients.
Study Setup: Who Was Included?
The research team analyzed 201 CSDH patients treated between January 2006 and June 2018. They split participants into three groups based on treatment:
- Non-endoscopic group (126 patients, 2006–2010): Traditional burr-hole drainage (local/general anesthesia).
- Endoscopic non-DFT group (31 patients, 2011–2018): Flexible neuroendoscopy, but operated in a liquid medium (constant lavage to keep the field clear).
- Endoscopic DFT group (44 patients, 2011–2018): Flexible neuroendoscopy in a dry field—first draining the hematoma cavity, then using the endoscope in the empty space to inspect and clean the area.
All patients met strict criteria:
- Symptoms (headache, vomiting, weakness, speech problems) or CT scans showing CSDH (crescent-shaped low density under the skull).
- No prior CSDH treatment or anticoagulants (e.g., aspirin) for ≥10 days.
- Excluded: Recurrent CSDH, severe systemic disease, or cognitive impairment preventing surgery.
The study followed the Declaration of Helsinki and was approved by Capital Medical University’s Institutional Review Board. All patients gave informed consent.
How Did the Surgeries Work?
For the non-endoscopic group, surgeons drilled a burr hole and drained the hematoma—standard practice.
For the endoscopic groups, surgery used general anesthesia:
- DFT group: First, surgeons drained the bloody fluid from the hematoma cavity. Then, they inserted the flexible endoscope into the dry space to:
- Inspect the cavity from all angles (no fluid to obscure the view).
- Remove residual clots or semi-solid blood.
- Pierce “real” septa (tissue walls dividing the hematoma) to ensure complete drainage.
- Replace any gas in the cavity with warm saline to reduce pneumocephalus risk.
- Non-DFT group: Surgeons relied on continuous lavage (washing with liquid) to keep the field clear—adding time and risking damage to the hematoma’s outer capsule.
Key Results: Safer, Faster, More Effective
The study’s findings were striking—no patients died, and the DFT group outperformed both other groups on nearly every metric:
| Metric | Endoscopic DFT | Endoscopic Non-DFT | Non-Endoscopic |
|---|---|---|---|
| Operative time | 37.4 minutes (shorter) | 68.8 minutes | 43.1 minutes |
| Hematoma clearance (1st post-op day) | 98.2% (higher) | 97.4% | 87.1% |
| Drainage tube placement | 20.1 hours (shorter) | 23.3 hours | 49.1 hours |
| Complication rate | 4.6% (lower) | 12.9% | 22.2% |
| Recurrence rate | 6.8% (lower) | 9.7% | 15.1% |
Other wins:
- Faster recovery: More DFT patients (72.7%) had a good functional outcome (modified Rankin Scale 0–3, meaning minimal to no disability) on the first post-op day vs. 50.8% in the non-endoscopic group.
- Fewer complications: Only 2 DFT patients had issues (pneumocephalus, fever) vs. 28 in the non-endoscopic group.
Why Does DFT Work So Well?
The study identified 7 key advantages of combining flexible neuroendoscopy with DFT:
- Clearer view: The dry field eliminates fluid-related blur, letting surgeons see every corner of the hematoma cavity.
- Better compartment management: CT scans can show “separated” CSDHs, but DFT lets surgeons tell if those walls are real (need piercing) or false (just clots). This cuts recurrence by ensuring complete drainage.
- Safer surgery: Dry fields improve depth perception—surgeons are less likely to damage nearby brain tissue.
- No endless lavage: Unlike non-DFT, DFT doesn’t require constant washing—saving time and preserving the hematoma’s outer capsule (reducing effusion risk).
- Easier hemostasis: Bleeding is easier to spot (and stop) in a dry field—critical for preventing post-op bleeding.
- Fewer effusions: Protecting the capsule means less fluid buildup after surgery.
- Simple to learn: DFT uses standard flexible neuroendoscopes—no extra tools needed—making it easier for surgeons to adopt.
Limitations and Future Research
As a retrospective study, the research can’t rule out all biases (e.g., doctors might have chosen healthier patients for the DFT group). The team notes that a prospective, randomized controlled trial (the gold standard for medical research) is needed to confirm these results.
Conclusion: A Promising New Standard
For patients with CSDH, flexible neuroendoscopy combined with dry-field techniques offers a safer, faster, more effective alternative to traditional burr-hole drainage. It reduces complications, cuts recurrence, and gets patients back to normal faster—without requiring expensive new tools.
While more research is needed, this study adds strong evidence that DFT could become a new standard in CSDH treatment. For older adults—who are most at risk for CSDH—this could mean fewer repeat surgeries and a better quality of life.
The original study was published in the Chinese Medical Journal (2019) by Feng Guan, Wei-Cheng Peng, Hui Huang, and colleagues from Beijing Shijitan Hospital, Capital Medical University.
doi: 10.1097/CM9.0000000000000249
Was this helpful?
0 / 0